VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 288,004 Value ($000) $3,234 Avg Close — Range —
Q1 2025
Shares 311,480 Value ($000) $1,423 Avg Close — Range —
Q4 2024
Shares 129,202 Value ($000) $729 Avg Close — Range —
Q3 2024
Shares 745,055 Value ($000) $3,606 Avg Close — Range —
Q2 2024
Shares 507,360 Value ($000) $2,476 Avg Close — Range —
Q1 2024
Shares 1,177,085 Value ($000) $15,632 Avg Close — Range —
Q4 2023
Shares 449,820 Value ($000) $6,270 Avg Close — Range —
Q3 2023
Shares 237,203 Value ($000) $3,145 Avg Close — Range —
Q2 2023
Shares 696,040 Value ($000) $13,051 Avg Close — Range —
Q1 2023
Shares 424,862 Value ($000) $6,127 Avg Close — Range —
Q4 2022
Shares 36,834 Value ($000) $713 Avg Close — Range —
Q3 2022
Shares 70,830 Value ($000) $2,433 Avg Close — Range —
Q2 2022
Shares 1,081,555 Value ($000) $16,526 Avg Close — Range —
Q1 2022
Shares 980,330 Value ($000) $22,371 Avg Close — Range —
Q4 2021
Shares 547,210 Value ($000) $20,176 Avg Close — Range —
Q3 2021
Shares 666,384 Value ($000) $30,508 Avg Close — Range —
Q2 2021
Shares 829,589 Value ($000) $48,701 Avg Close — Range —